Metraipolis › archive › dc_b623e2a33475

Targeted peptide modification of mesenchymal stem cells enhances their therapeutic efficacy in the treatment of idiopathic pulmonary fibrosis — Europe PMC PMID:41487997

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41487997
DOI
10.3389/fcell.2025.1710750
License (as archived)
solo-consultazione
Archived
2026-11-07T13:39:40.180Z
SHA-256 of the archived text
ce4f7262035c2435195e183ac1e7e00f1e0609f02bf53fc63c551e565728d36c
Stable URL of this page
https://metraipolis.com/documento/dc_b623e2a33475

How to cite

Targeted peptide modification of mesenchymal stem cells enhances their therapeutic efficacy in the treatment of idiopathic pulmonary fibrosis — Europe PMC PMID:41487997 — Europe PMC (en), https://europepmc.org/article/MED/41487997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b623e2a33475 (Metraipolis archive dc_b623e2a33475, sha256 ce4f7262035c2435195e183ac1e7e00f1e0609f02bf53fc63c551e565728d36c)
BibTeX
@misc{dcb623e2a33475,
  title = {Targeted peptide modification of mesenchymal stem cells enhances their therapeutic efficacy in the treatment of idiopathic pulmonary fibrosis — Europe PMC PMID:41487997},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41487997},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b623e2a33475; sha256 ce4f7262035c2435195e183ac1e7e00f1e0609f02bf53fc63c551e565728d36c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41487997. Agents can read the archived copy with the MCP tool read_document.